Table 1_Taking stock of psychosocial rehabilitation in children and adolescents: a systematic review with meta-analysis.docx di Liesa J. Weiler-Wichtl (22686938)

Soggetti:

Table 2_Taking stock of psychosocial rehabilitation in children and adolescents: a systematic review with meta-analysis.docx di Liesa J. Weiler-Wichtl (22686938)

Soggetti:

Limb lengthening: slower distraction rate may expedite joint recovery di HUI TANG (22420714)

Soggetti:

Table 1_BAG3-related myofibrillar myopathy: focus on its cardiac involvement.docx di Elise Daire (22685165)

Soggetti:

Table 2_BAG3-related myofibrillar myopathy: focus on its cardiac involvement.xlsx di Elise Daire (22685165)

Soggetti:

Supplementary Table S5 from Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in Rhabdomyosarcoma di Srivandana Akshintala (16610490)

Soggetti:

Supplementary Dataset S1 from Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in Rhabdomyosarcoma di Srivandana Akshintala (16610490)

Soggetti:

Figure S5 from The Oncolytic Adenovirus XVir-N-31 Joins Forces with CDK4/6 Inhibition Augmenting Innate and Adaptive Antitumor Immunity in Ewing Sarcoma di Sebastian Johannes Schober (14971891)

Soggetti:

Figure S2 from The Oncolytic Adenovirus XVir-N-31 Joins Forces with CDK4/6 Inhibition Augmenting Innate and Adaptive Antitumor Immunity in Ewing Sarcoma di Sebastian Johannes Schober (14971891)

Soggetti:

Figure S4 from The Oncolytic Adenovirus XVir-N-31 Joins Forces with CDK4/6 Inhibition Augmenting Innate and Adaptive Antitumor Immunity in Ewing Sarcoma di Sebastian Johannes Schober (14971891)

Soggetti:

Figure S3 from The Oncolytic Adenovirus XVir-N-31 Joins Forces with CDK4/6 Inhibition Augmenting Innate and Adaptive Antitumor Immunity in Ewing Sarcoma di Sebastian Johannes Schober (14971891)

Soggetti:

Figure S1 from The Oncolytic Adenovirus XVir-N-31 Joins Forces with CDK4/6 Inhibition Augmenting Innate and Adaptive Antitumor Immunity in Ewing Sarcoma di Sebastian Johannes Schober (14971891)

Soggetti:

Supplementary Table S2 from Transcriptional Antagonism by CDK8 Inhibition Improves Therapeutic Efficacy of MEK Inhibitors di Clare F. Malone (14960925)

Soggetti:

Supplementary Table S3 from Transcriptional Antagonism by CDK8 Inhibition Improves Therapeutic Efficacy of MEK Inhibitors di Clare F. Malone (14960925)

Soggetti:

Supplementary Table S1 from Transcriptional Antagonism by CDK8 Inhibition Improves Therapeutic Efficacy of MEK Inhibitors di Clare F. Malone (14960925)

Soggetti:

Table S1 from Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution di Bahar Rastegar (16031079)

Soggetti:

Table S4 from Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution di Bahar Rastegar (16031079)

Soggetti:

Table S3 from Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution di Bahar Rastegar (16031079)

Soggetti:

Table S5 from Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma di Gia-Buu Tran (16437051)

Soggetti:

Table S3 from Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma di Gia-Buu Tran (16437051)

Soggetti: